Radiation damage remains the principal limitation in achieving higher resolution in cryo-electron microscopy (cryo-EM), ...

Investigators evaluated the effectiveness of an immunotherapy in combination with standard radiation therapy for patients with intermediate-high risk localized prostate cancer.

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

The global radiation oncology market size was US$ 7.7 billion in 2021. The global radiation oncology market size is estimated to reach US$ 15.1 billion by 2030, growing at a compound annual growth ...

The Phase 1/2a trial is a two-part, single-arm, prospective study aimed at determining the maximum tolerated dose (MTD), safety, and tolerability of REYOBIQ in pediatric patients aged 6 to 21 years ...

252160 Introduction: Positron Emission Tomography (PET) for real-time guidance in external beam radiation delivery is rapidly evolving. This approach enables more precise targeting by reducing beam ...

Five months after revealing results of a successful prostate cancer trial, Candel has shown more data from the study, bolstering the value of CAN-2409.

External beam radiation is the most common type of radiation therapy. It precisely targets cancer cells while minimizing damage to the surrounding area.

By Vidhi Prasad K.V. Advancements in radiation therapy have made this treatment a fundamental component of cancer care. An ...

The U.S. radiation oncology market is calculated at USD 6.65 billion in the year 2023, which grew at USD 7.19 billion in the year 2024 and is estimated to reach around USD 14.56 billion in the year ...

With minimal exit dose, proton beam therapy might allow for decreased radiation exposure to the uninvolved hepatic parenchyma, potentially preserving long-term liver function. 6 These technological ...